130 related articles for article (PubMed ID: 35302641)
1. Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor Immunity.
Han M; Nguyen B; Lee JY; Browning E; Zhang J; Mukhopadhyay A; Gujar R; Salazar J; Hermiz R; Svenson L; Rolig AS; Redmond WL; Algazi AP; Daud AI; Canton DA; Twitty CG
Mol Cancer Res; 2022 Jun; 20(6):983-995. PubMed ID: 35302641
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral Delivery of Plasmid IL12 Via Electroporation Leads to Regression of Injected and Noninjected Tumors in Merkel Cell Carcinoma.
Bhatia S; Longino NV; Miller NJ; Kulikauskas R; Iyer JG; Ibrani D; Blom A; Byrd DR; Parvathaneni U; Twitty CG; Campbell JS; Le MH; Gargosky S; Pierce RH; Heller R; Daud AI; Nghiem P
Clin Cancer Res; 2020 Feb; 26(3):598-607. PubMed ID: 31582519
[TBL] [Abstract][Full Text] [Related]
3. Intratumoral Plasmid IL12 Electroporation Therapy in Patients with Advanced Melanoma Induces Systemic and Intratumoral T-cell Responses.
Greaney SK; Algazi AP; Tsai KK; Takamura KT; Chen L; Twitty CG; Zhang L; Paciorek A; Pierce RH; Le MH; Daud AI; Fong L
Cancer Immunol Res; 2020 Feb; 8(2):246-254. PubMed ID: 31852717
[TBL] [Abstract][Full Text] [Related]
4. Intratumoral Plasmid IL12 Expands CD8
Telli ML; Nagata H; Wapnir I; Acharya CR; Zablotsky K; Fox BA; Bifulco CB; Jensen SM; Ballesteros-Merino C; Le MH; Pierce RH; Browning E; Hermiz R; Svenson L; Bannavong D; Jaffe K; Sell J; Foerter KM; Canton DA; Twitty CG; Osada T; Lyerly HK; Crosby EJ
Clin Cancer Res; 2021 May; 27(9):2481-2493. PubMed ID: 33593880
[TBL] [Abstract][Full Text] [Related]
5. Intratumoral IL12 mRNA Therapy Promotes TH1 Transformation of the Tumor Microenvironment.
Hewitt SL; Bailey D; Zielinski J; Apte A; Musenge F; Karp R; Burke S; Garcon F; Mishra A; Gurumurthy S; Watkins A; Arnold K; Moynihan J; Clancy-Thompson E; Mulgrew K; Adjei G; Deschler K; Potz D; Moody G; Leinster DA; Novick S; Sulikowski M; Bagnall C; Martin P; Lapointe JM; Si H; Morehouse C; Sedic M; Wilkinson RW; Herbst R; Frederick JP; Luheshi N
Clin Cancer Res; 2020 Dec; 26(23):6284-6298. PubMed ID: 32817076
[TBL] [Abstract][Full Text] [Related]
6. Melanoma treatment with intratumoral electroporation of tavokinogene telseplasmid (pIL-12, tavokinogene telseplasmid).
Canton DA; Shirley S; Wright J; Connolly R; Burkart C; Mukhopadhyay A; Twitty C; Qattan KE; Campbell JS; Le MH; Pierce RH; Gargosky S; Daud A; Algazi A
Immunotherapy; 2017 Dec; 9(16):1309-1321. PubMed ID: 29064334
[TBL] [Abstract][Full Text] [Related]
7. Administration route- and immune cell activation-dependent tumor eradication by IL12 electrotransfer.
Li S; Zhang L; Torrero M; Cannon M; Barret R
Mol Ther; 2005 Nov; 12(5):942-9. PubMed ID: 15953768
[TBL] [Abstract][Full Text] [Related]
8. Electrochemo-gene therapy of cancer: intratumoral delivery of interleukin-12 gene and bleomycin synergistically induced therapeutic immunity and suppressed subcutaneous and metastatic melanomas in mice.
Kishida T; Asada H; Itokawa Y; Yasutomi K; Shin-Ya M; Gojo S; Cui FD; Ueda Y; Yamagishi H; Imanishi J; Mazda O
Mol Ther; 2003 Nov; 8(5):738-45. PubMed ID: 14599806
[TBL] [Abstract][Full Text] [Related]
9. Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor immunity.
Lee JY; Nguyen B; Mukhopadhyay A; Han M; Zhang J; Gujar R; Salazar J; Hermiz R; Svenson L; Browning E; Lyerly HK; Canton DA; Fisher D; Daud A; Algazi A; Skitzki J; Twitty CG
Mol Ther Oncolytics; 2022 Jun; 25():174-188. PubMed ID: 35592387
[TBL] [Abstract][Full Text] [Related]
10. Plasmid IL-12 electroporation in melanoma.
Cha E; Daud A
Hum Vaccin Immunother; 2012 Nov; 8(11):1734-8. PubMed ID: 23151447
[TBL] [Abstract][Full Text] [Related]
11. Oncolytic adenovirus coexpressing interleukin-12 and shVEGF restores antitumor immune function and enhances antitumor efficacy.
Ahn HM; Hong J; Yun CO
Oncotarget; 2016 Dec; 7(51):84965-84980. PubMed ID: 27821803
[TBL] [Abstract][Full Text] [Related]
12. Intratumoral delivery of tavokinogene telseplasmid yields systemic immune responses in metastatic melanoma patients.
Algazi A; Bhatia S; Agarwala S; Molina M; Lewis K; Faries M; Fong L; Levine LP; Franco M; Oglesby A; Ballesteros-Merino C; Bifulco CB; Fox BA; Bannavong D; Talia R; Browning E; Le MH; Pierce RH; Gargosky S; Tsai KK; Twitty C; Daud AI
Ann Oncol; 2020 Apr; 31(4):532-540. PubMed ID: 32147213
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral Gene Transfer of mRNAs Encoding IL12 in Combination with Decoy-Resistant IL18 Improves Local and Systemic Antitumor Immunity.
Cirella A; Bolaños E; Di Trani CA; de Andrea CE; Sánchez-Gregorio S; Etxeberria I; Gonzalez-Gomariz J; Olivera I; Brocco D; Glez-Vaz J; Luri-Rey C; Azpilikueta A; Rodríguez I; Fernandez-Sendín M; Egea J; Eguren I; Sanmamed MF; Palencia B; Teijeira A; Berraondo P; Melero I
Cancer Immunol Res; 2023 Feb; 11(2):184-198. PubMed ID: 36478221
[TBL] [Abstract][Full Text] [Related]
14. Candidate genes associated with tumor regression mediated by intratumoral IL-12 electroporation gene therapy.
Li S; Xia X; Mellieon FM; Liu J; Steele S
Mol Ther; 2004 Mar; 9(3):347-54. PubMed ID: 15006601
[TBL] [Abstract][Full Text] [Related]
15. Improving therapeutic efficacy of IL-12 intratumoral gene electrotransfer through novel plasmid design and modified parameters.
Burkart C; Mukhopadhyay A; Shirley SA; Connolly RJ; Wright JH; Bahrami A; Campbell JS; Pierce RH; Canton DA
Gene Ther; 2018 Apr; 25(2):93-103. PubMed ID: 29523878
[TBL] [Abstract][Full Text] [Related]
16. Characterization of abscopal effects of intratumoral electroporation-mediated IL-12 gene therapy.
Mukhopadhyay A; Wright J; Shirley S; Canton DA; Burkart C; Connolly RJ; Campbell JS; Pierce RH
Gene Ther; 2019 Feb; 26(1-2):1-15. PubMed ID: 30323352
[TBL] [Abstract][Full Text] [Related]
17. Engineered Mesenchymal Stem Cells as a Biotherapy Platform for Targeted Photodynamic Immunotherapy of Breast Cancer.
Zhang H; Feng Y; Xie X; Song T; Yang G; Su Q; Li T; Li S; Wu C; You F; Liu Y; Yang H
Adv Healthc Mater; 2022 Mar; 11(6):e2101375. PubMed ID: 34981675
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral DNA-based delivery of checkpoint-inhibiting antibodies and interleukin 12 triggers T cell infiltration and anti-tumor response.
Jacobs L; Yshii L; Junius S; Geukens N; Liston A; Hollevoet K; Declerck P
Cancer Gene Ther; 2022 Jul; 29(7):984-992. PubMed ID: 34754076
[TBL] [Abstract][Full Text] [Related]
19. Intratumoral injection of dendritic cells overexpressing interleukin‑12 inhibits melanoma growth.
Yao W; Li Y; Zeng L; Zhang X; Zhou Z; Zheng M; Wan H
Oncol Rep; 2019 Jul; 42(1):370-376. PubMed ID: 31115558
[TBL] [Abstract][Full Text] [Related]
20. Tumor-infiltrating lymphocytes genetically engineered with an inducible gene encoding interleukin-12 for the immunotherapy of metastatic melanoma.
Zhang L; Morgan RA; Beane JD; Zheng Z; Dudley ME; Kassim SH; Nahvi AV; Ngo LT; Sherry RM; Phan GQ; Hughes MS; Kammula US; Feldman SA; Toomey MA; Kerkar SP; Restifo NP; Yang JC; Rosenberg SA
Clin Cancer Res; 2015 May; 21(10):2278-88. PubMed ID: 25695689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
